Presentation is loading. Please wait.

Presentation is loading. Please wait.

Sex-associated differences in survival of patients undergoing resection for lung cancer  Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Published byGodwin Andrews Modified over 5 years ago

Similar presentations

Presentation on theme: "Sex-associated differences in survival of patients undergoing resection for lung cancer  Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel."— Presentation transcript:

1 Sex-associated differences in survival of patients undergoing resection for lung cancer 
Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel J Haraf, MD, Jemi Olak, MD, Gregory A Masters, MD, Everett E Vokes, MD  The Annals of Thoracic Surgery  Volume 69, Issue 1, Pages (January 2000) DOI: /S (99)

2 Fig 1 Kaplan-Meier survival curves according to stage for patients who underwent major lung resection for lung cancer. Vertical hatch marks represent censored data points. Error bars represent 95% confidence intervals. The Annals of Thoracic Surgery  , DOI: ( /S (99) )

3 Fig 2 Kaplan-Meier survival curves for all stages combined for men and women who underwent major lung resection for lung cancer. Vertical hatch marks represent censored data points. Error bars represent 95% confidence intervals. Numbers at bottom indicate patients available for evaluation at each time point. (M = men; W = women.) The Annals of Thoracic Surgery  , DOI: ( /S (99) )

4 Fig 3 Kaplan-Meier survival curves according to stage (A, Stage I; B, Stage II; and C, Stage III) for men and women who underwent major lung resection for lung cancer. Vertical hatch marks represent censored data points. Error bars represent 95% confidence intervals. Numbers at bottom indicate patients available for evaluation at each time point. (M = men; W = women.) The Annals of Thoracic Surgery  , DOI: ( /S (99) )

Download ppt "Sex-associated differences in survival of patients undergoing resection for lung cancer  Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel."

Similar presentations

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.
Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 
Primary non-Hodgkin’s lymphoma of the lung

Primary non-Hodgkin’s lymphoma of the lung
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind,

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind,
Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema  Eugenio Pompeo, MD, Enrico De Dominicis,

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema  Eugenio Pompeo, MD, Enrico De Dominicis,
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer  Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer  Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1  Mark J Krasna, MD, Carolyn E Reed,

Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1  Mark J Krasna, MD, Carolyn E Reed,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Heart Transplantation for the Failing Fontan

Heart Transplantation for the Failing Fontan
Surgery for coarctation of the aorta in infants weighing less than 2 kg  Emile A Bacha, MD, Melvin Almodovar, MD, David L Wessel, MD, David Zurakowski,

Surgery for coarctation of the aorta in infants weighing less than 2 kg  Emile A Bacha, MD, Melvin Almodovar, MD, David L Wessel, MD, David Zurakowski,
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Similar presentations

Ads by Google